1. Home
  2. EPRT vs RYTM Comparison

EPRT vs RYTM Comparison

Compare EPRT & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Essential Properties Realty Trust Inc.

EPRT

Essential Properties Realty Trust Inc.

N/A

Current Price

$28.09

Market Cap

5.9B

Sector

Real Estate

ML Signal

N/A

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

N/A

Current Price

$113.20

Market Cap

6.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EPRT
RYTM
Founded
2016
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
6.3B
IPO Year
2018
2017

Fundamental Metrics

Financial Performance
Metric
EPRT
RYTM
Price
$28.09
$113.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
18
19
Target Price
$33.19
★ $139.76
AVG Volume (30 Days)
★ 2.9M
1.8M
Earning Date
10-21-2026
11-03-2026
Dividend Yield
★ 4.61%
N/A
EPS Growth
11.30
★ 28.34
EPS
★ 0.90
N/A
Revenue
★ $561,219,000.00
N/A
Revenue This Year
$18.58
$74.20
Revenue Next Year
$16.17
$74.91
P/E Ratio
$30.88
★ N/A
Revenue Growth
★ 24.82
N/A
52 Week Low
$24.62
$74.50
52 Week High
$34.73
$122.20

Technical Indicators

Market Signals
Indicator
EPRT
RYTM
Relative Strength Index (RSI) 59.23 57.34
Support Level $24.67 $100.33
Resistance Level $28.46 $113.31
Average True Range (ATR) 0.51 8.32
MACD 0.02 0.87
Stochastic Oscillator 72.08 78.21

Price Performance

Historical Comparison
EPRT
RYTM

About EPRT Essential Properties Realty Trust Inc.

Essential Properties Realty Trust Inc is a real estate investment trust. It is an internally managed real estate company acquires, owns and manages single-tenant properties that are net leased on a long-term basis to middle-market companies operating service-oriented or experience-based businesses. The Company generally invests in and leases freestanding, single-tenant commercial real estate facilities where a tenant services its customers and conducts activities that are essential to the generation of the tenant's sales and profits.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

Share on Social Networks: